DWA
ANIX icon

Dorsey Wright & Associates’s Anixa Biosciences ANIX Stock Holding History

Dorsey Wright & Associates’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,093
Closed -$37.9K – 293
2021
Q1 		$37.9K Buy
+8,093
New +$38.7K 0.45% 114

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dorsey Wright & Associates's ANIX Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of Anixa Biosciences (ANIX) in Q2 2021, closing a stake of 8,093 shares — an estimated $37.9K sold.

Dorsey Wright & Associates first reported a position in ANIX in Q1 2021 and held it in 1 quarter. The position peaked at $37.9K in Q1 2021. 32 funds tracked by Wall St. Rank hold ANIX as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining Anixa Biosciences position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 8,093 Anixa Biosciences shares in Q2 2021, an estimated $37.9K.
  • Dorsey Wright & Associates first reported a position in Anixa Biosciences in Q1 2021 and held it in 1 quarter.
  • Dorsey Wright & Associates's Anixa Biosciences position peaked at $37.9K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.